CHR’s COVID-19 Bulletin, April 22, 2020

[This article deals with a continuously developing situation. It was written by Norbert Gleicher, MD, on April 22, 2020 and published on April 22, 2020. For a list of all COVID-19 Bulletins, scroll to the bottom.] 

We have not published a Bulletin for almost a week because there has not much been happening regarding the COVID-19 pandemic. Efforts to “reopen” the country appear to be gaining strength but New York state does not appear to be on the forefront of such activities. That is on the one hand understandable because the state, especially New York City, has been a hotbed of COVID-19 infection. On the other hand, considering the economic importance of New York City for the whole country, the impact of keeping the city shut down must be seriously considered.

We are pleased to report that some of the major hospitals are getting ready to resume pre-COVID-19 health care. That, too, of course, represents a degree of “reopening” the city.

COVID-19 came to the U.S. already in January

Likely the most significantnew reporting on COVID-19 in recent days was the recognition that the first two deaths caused by the virus happened in Washington State much earlier than previously reported. Autopsies of deaths on February 6 of this year now established beyond doubt that they were COVID-19 cases. Because both of these deaths were the consequence of community transmission, this finding strongly suggests that the virus entered the U.S. already in January. We, therefore, already into the fourth month of the pandemic in this country.

Reciprocal collaboration among IVF centers on the wane?

Finally, we are sorry to report that most IVF centers remain closed in the US. As indicated in our last Bulletin, we had hoped that some of our colleagues may start reopening their centers but, so far, not much has been happening. 

We also must express a degree of disappointment with IVF centers that have remained open. To our surprise, at least some of them now refuse to offer routine cycle monitoring for CHR patients who live outside of NYC, as was reciprocal, collaborative practice before the COVID-19 crisis broke. The excuse is that they are “too busy,” which really does not make much sense because all IVF centers, even those that remained open, have seen a significant decline in patient volume. 

It is disappointing to see that, instead of becoming more collaborative, these centers are going the opposite way during the COVID-19 crisis. CHR, of course, does not do that, and will gladly monitor patients from centers outside of NYC at their behalf whenever that becomes necessary.

CHR’s COVID-19 Bulletins

  1. COVID-19 accelerating the changing practice of assisted reproduction (published on October 16, 2020)
  2. [Preprint by Norbert Gleicher, MD] COVID-10 pandemic through the eyes of a New York City fertility center (published on August 20, 2020)
  3. News you, likely, will not find in the media (Published on July 6, 2020)
  4. Notable reports in medical literature and the media on COVID-19 and immunity against it (Published on July 6, 2020)
  5. COVID-19 cases rapidly increase in South and Western U.S. states but that will help build herd immunity (Published on June 29, 2020)
  6. Are we witnessing a second wave of COVID-19 outbreak? (Published on June 22, 2020)
  7. WHO was wrong about asymptomatic patients being contagious & other COVID-19 fake news (Published on June 10, 2020)
  8. Updated COVID-19 precautions at CHR (Published on June 9, 2020)
  9. What we now know about COVID-19 and what it means for mitigation strategies (Published on May 22, 2020)
  10. COVID-19 response in retrospect, as well as going forward (Published on May 7, 2020)
  11. The essence of the COVID-19 pandemic (Published on May 7, 2020)
  12. Practical consequences of COVID-19 for CHR’s fertility patients (Published May 7, 2020)
  13. IVF after COVID-19: ASRM and SART release reopening guidelines for IVF centers (Published on 4/29/2020)
  14. One medical expert, missing from all COVID-19 task forces, who should be listened to (Published on 4/29/2020)
  15. Governments worldwide should have let herd immunity develop rather than cause one of the worst recessions on wild guesses of “experts” (Published 4/27/2020)
  16. Reciprocal collaboration among IVF centers for cycle monitoring may be on the wane (Published 4/22/2020)
  17. Is embryo freezing better than IVF during COVID-19 outbreak? (Published on 4/17/2020)
  18. When to restart fertility treatments after COVID-19 (Published on 4/17/2020)
  19. “Reopening” of fertility centers after COVID-19: How that may look like (Published on 4/17/2020)
  20. Some IVF centers may never reopen (Published on 4/17/2020)
  21. Skepticism warranted for “expert opinions” on COVID-19 (Published on 4/13/2020)
  22. Fertility Providers’ Alliance tries to reframe ASRM’s reaffirmation of COVID-19 guidelines as FPA victory (Published on 4/6/2020)
  23. States in the Northeast may see first signs of “flattening the curve” (Published on 4/6/2020)
  24. Reported death rate exaggerated by the media, shelter in place or herd immunity, first COVID-19 antibody test approved, and more (Published on 4/3/2020)
  25. What can I do to continue on my fertility journey? [VIDEO] (Filmed on 3/26/2020, published on 4/2/2020)
  26. “Controversy” over ASRM recommendation hints at investor interest’s power grab amid COVID-19 pandemic (Published on 4/2/2020)
  27. Pregnant women concerned over delivery and babies during COVID-19 pandemic (Published 4/1/2020)
  28. ASRM’s COVID-19 Task Force reaffirms previous recommendations (Published 4/1/2020)
  29. To stay open or not: IVF centers argue over ASRM guidelines on COVID-19 and fertility treatments (Published 3/27/2020)
  30. Concerning news on COVID-19’s effects on pregnancy and newborn (Published 3/27/2020)
  31. What’s urgent is urgent and what’s not urgent isn’t: Explaining ASRM recommendations on fertility treatments during COVID-19 pandemic (Published 3/26/2020)
  32. Patient autonomy and “do no harm” principles mean CHR continues to offer fertility diagnosis and treatments during COVID-19 crisis (Published 3/23/2020)
  33. ASRM and SART’s recommendations on fertility treatment during COVID-19 outbreak (Published 3/18/2020)
  34. CHR’s response to the COVID-19 outbreak: What we are doing to protect our patients, staff and community (Published 3/13/2020)
  35. Does COVID-19 have an effect on fertility? (Published 3/13/2020) 
  36. What happens if I get quarantined during an IVF cycle? (Published 3/13/2020)
  37. What happens if CHR is closed for quarantine during my IVF cycle? (Published 3/13/2020) 
  38. What should fertility patients do during the coronavirus outbreak? (Published 3/13/2020) 
  39. Should international patients of IVF do anything differently during the outbreak? (Published 3/13/2020) 
Norbert Gleicher, MD, leads CHR’s clinical and research efforts as Medical Director and Chief Scientist. A world-renowned specialist in reproductive endocrinology, Dr. Gleicher has published hundreds of peer-reviewed papers and lectured globally while keeping an active clinical career focused on ovarian aging, immunological issues and other difficult cases of infertility.